Home › Funds › Hardman Johnston Global Advisors LLC › JAZZ

Hardman Johnston Global Advisors LLC position in JAZZ

JAZZ PHARMACEUTICALS PLC · Health Care

Hardman Johnston Global Advisors LLC reported holding 30,172 shares of JAZZ (JAZZ PHARMACEUTICALS PLC) in its Q3 2026 13F filing — a position valued at US$7.0M, representing 0.21% of its reported portfolio and ranking #48 among its reported holdings. Hardman Johnston Global Advisors LLC has disclosed JAZZ holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)30.17K sh
Reported value held$6.99M
Portfolio Weight0.21%
First reportedQ2 2026
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Hardman Johnston Global Advisors LLC's JAZZ position evolved

Hardman Johnston Global Advisors LLC first disclosed a stake in JAZZ in Q2 2026 at 28,817 shares (US$6.9M). The position peaked in Q3 2026 at 30,172 shares, worth US$7.0M. Across 2 filings, Hardman Johnston Global Advisors LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 30,172 shares valued at US$7.0M — an increase of 1,355 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q2 2026 28.82K $6.94M New
Q3 2026 30.17K $6.99M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JAZZ and 13F data

JAZZ (JAZZ PHARMACEUTICALS PLC) is a Health Care company. 41 other funds we track also report a position in JAZZ — the largest reported positions include FULLER & THALER ASSET MANAGEMENT, INC. (US$323.8M), MILLENNIUM MANAGEMENT LLC (US$184.1M), Boston Trust Walden Corp (US$98.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JAZZ

All JAZZ fund holders →

FAQ

How long has Hardman Johnston Global Advisors LLC held JAZZ?

Hardman Johnston Global Advisors LLC has disclosed JAZZ holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Hardman Johnston Global Advisors LLC's current position in JAZZ?

As of Q3 2026, Hardman Johnston Global Advisors LLC holds 30.17K shares of JAZZ (JAZZ PHARMACEUTICALS PLC), valued at $6.99M, representing 0.21% of its reported portfolio and ranking #48.

Has Hardman Johnston Global Advisors LLC been buying or selling JAZZ?

In the latest 13F filing (Q3 2026), Hardman Johnston Global Advisors LLC increased its position in JAZZ. The position peaked in Q3 2026 at 30.17K shares.

Which other funds hold JAZZ?

Other major institutional holders of JAZZ include FULLER & THALER ASSET MANAGEMENT, INC., MILLENNIUM MANAGEMENT LLC, Boston Trust Walden Corp, among 41 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.